United States Biotechnology & Medical Research

Harpoon Therapeutics Inc (HARP)

Track

Ticker: HARP Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Harpoon Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 11 Mar 2024
Value US$1,227,200.19 | Price 490.57 | Shares 31,746 (+9.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-11 2024-03-11 B Purchase
0.7
Merck & Co., Inc.
Large shareholder
31,746 +9.5%
490.57
US$1,227,200 		31,746 +9.5% 490.57 US$1,227,200
2023-10-27 2023-10-25 B Purchase
0.6
HUNT RONALD
Non-Executive Director Large shareholder
35,279
397.80
US$239,733 		35,279 397.80 US$239,733
2023-10-27 2023-10-25 B Purchase
0.6
HUNT RONALD
Non-Executive Director Large shareholder
45,065
102.07
US$1,094,540 		45,065 102.07 US$1,094,540
2023-10-27 2023-10-25 B Purchase
New Leaf Biopharma Opportunities II, L.P.
Large shareholder
171,500
0.00
US$0 		171,500 0.00 US$0
2023-10-27 2023-10-25 B Purchase
New Leaf Biopharma Opportunities II, L.P.
Large shareholder
1,372,000
0.00
US$0 		1,372,000 0.00 US$0
2023-03-27 2023-03-23 B Purchase
0.6
HUNT RONALD
Non-Executive Director Large shareholder
10,000 +inf%
1,000.00
US$10,000,000 		10,000 +inf% 1,000.00 US$10,000,000
2021-07-06 2021-07-01 PlS Planned sale
Wesche Holger

Chief Scientific Officer

Officer
10,000 -15.9%
14.00
US$140,000 		10,000 -15.9% 14.00 US$140,000
2021-06-02 2021-06-02 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
25,118 -0.4%
20.50
US$514,919 		25,118 -0.4% 20.50 US$514,919
2021-06-02 2021-06-01 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
18,491 -0.3%
20.44
US$377,956 		18,491 -0.3% 20.44 US$377,956
2021-06-02 2021-05-28 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
100 -0.0%
22.60
US$2,260 		100 -0.0% 22.60 US$2,260
2021-06-02 2021-05-28 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
3,100 -0.0%
21.92
US$67,952 		3,100 -0.0% 21.92 US$67,952
2021-06-02 2021-05-28 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
10,685 -0.2%
20.88
US$223,103 		10,685 -0.2% 20.88 US$223,103
2021-05-27 2021-05-27 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
13,961 -0.2%
20.26
US$282,850 		13,961 -0.2% 20.26 US$282,850
2021-05-27 2021-05-26 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
3,198 -0.0%
20.04
US$64,088 		3,198 -0.0% 20.04 US$64,088
2021-05-24 2021-05-24 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
5,000 -0.1%
20.12
US$100,600 		5,000 -0.1% 20.12 US$100,600
2021-05-24 2021-05-21 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
10,907 -0.2%
20.21
US$220,430 		10,907 -0.2% 20.21 US$220,430
2021-05-12 2021-05-12 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
29,684 -0.5%
20.53
US$609,413 		29,684 -0.5% 20.53 US$609,413
2021-05-12 2021-05-11 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
7,672 -0.1%
21.51
US$165,025 		7,672 -0.1% 21.51 US$165,025
2021-05-12 2021-05-11 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
13,773 -0.2%
20.96
US$288,682 		13,773 -0.2% 20.96 US$288,682
2021-05-12 2021-05-10 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
411 -0.0%
22.46
US$9,231 		411 -0.0% 22.46 US$9,231
2021-05-12 2021-05-10 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
16,722 -0.3%
21.78
US$364,205 		16,722 -0.3% 21.78 US$364,205
2021-05-06 2021-05-05 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
59 -0.0%
23.09
US$1,362 		59 -0.0% 23.09 US$1,362
2021-05-06 2021-05-05 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
10,113 -0.2%
22.52
US$227,745 		10,113 -0.2% 22.52 US$227,745
2021-05-04 2021-05-04 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
3,500 -0.1%
23.33
US$81,655 		3,500 -0.1% 23.33 US$81,655
2021-05-04 2021-05-04 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
26,230 -0.4%
23.03
US$604,077 		26,230 -0.4% 23.03 US$604,077
2021-05-04 2021-05-03 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
4,401 -0.1%
23.45
US$103,203 		4,401 -0.1% 23.45 US$103,203
2021-05-04 2021-05-03 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
26,365 -0.4%
23.03
US$607,186 		26,365 -0.4% 23.03 US$607,186
2021-05-04 2021-04-30 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
268,023 -3.9%
22.35
US$5,990,314 		268,023 -3.9% 22.35 US$5,990,314
2021-04-29 2021-04-29 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
21,781 -0.3%
22.54
US$490,944 		21,781 -0.3% 22.54 US$490,944
2021-04-29 2021-04-29 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
45,511 -0.7%
22.02
US$1,002,152 		45,511 -0.7% 22.02 US$1,002,152
2021-04-29 2021-04-28 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
36,803 -0.5%
22.01
US$810,034 		36,803 -0.5% 22.01 US$810,034
2021-04-29 2021-04-28 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
14,219 -0.2%
21.64
US$307,699 		14,219 -0.2% 21.64 US$307,699
2021-04-29 2021-04-27 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
8,328 -0.1%
21.26
US$177,053 		8,328 -0.1% 21.26 US$177,053
2021-04-29 2021-04-27 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
3,501 -0.0%
20.99
US$73,486 		3,501 -0.0% 20.99 US$73,486
2021-04-22 2021-04-21 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
555 -0.0%
19.48
US$10,811 		555 -0.0% 19.48 US$10,811
2021-04-22 2021-04-21 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
8,417 -0.1%
18.94
US$159,418 		8,417 -0.1% 18.94 US$159,418
2021-04-20 2021-04-20 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
834 -0.0%
19.09
US$15,921 		834 -0.0% 19.09 US$15,921
2021-04-20 2021-04-20 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
21,415 -0.3%
18.70
US$400,460 		21,415 -0.3% 18.70 US$400,460
2021-04-20 2021-04-19 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
100 -0.0%
20.08
US$2,008 		100 -0.0% 20.08 US$2,008
2021-04-20 2021-04-19 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
9,956 -0.1%
19.29
US$192,051 		9,956 -0.1% 19.29 US$192,051
2021-04-20 2021-04-16 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
300 -0.0%
20.56
US$6,168 		300 -0.0% 20.56 US$6,168
2021-04-20 2021-04-16 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
5,547 -0.1%
19.82
US$109,942 		5,547 -0.1% 19.82 US$109,942
2021-04-15 2021-04-15 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.

Former 10% Owner
1,052 -0.0%
20.49
US$21,555 		1,052 -0.0% 20.49 US$21,555
2021-04-15 2021-04-15 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
8,696 -0.1%
20.49
US$178,181 		8,696 -0.1% 20.49 US$178,181
2021-04-15 2021-04-14 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.

Former 10% Owner
1,550 -0.0%
20.83
US$32,286 		1,550 -0.0% 20.83 US$32,286
2021-04-15 2021-04-14 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.

Former 10% Owner
121 -0.0%
20.06
US$2,427 		121 -0.0% 20.06 US$2,427
2021-04-15 2021-04-14 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
12,806 -0.2%
20.83
US$266,749 		12,806 -0.2% 20.83 US$266,749
2021-04-15 2021-04-14 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
1,000 -0.0%
20.06
US$20,060 		1,000 -0.0% 20.06 US$20,060
2021-04-15 2021-04-13 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.

Former 10% Owner
286 -0.0%
20.08
US$5,743 		286 -0.0% 20.08 US$5,743
2021-04-15 2021-04-13 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.

Former 10% Owner
1,657 -0.1%
19.35
US$32,063 		1,657 -0.1% 19.35 US$32,063
2021-04-15 2021-04-13 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
2,362 -0.0%
20.08
US$47,429 		2,362 -0.0% 20.08 US$47,429
2021-04-15 2021-04-13 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
13,692 -0.2%
19.35
US$264,940 		13,692 -0.2% 19.35 US$264,940
2021-04-13 2021-04-12 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
400 -0.0%
22.68
US$9,072 		400 -0.0% 22.68 US$9,072
2021-04-13 2021-04-12 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
6,700 -0.1%
21.52
US$144,184 		6,700 -0.1% 21.52 US$144,184
2021-04-13 2021-04-12 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
13,528 -0.2%
20.72
US$280,300 		13,528 -0.2% 20.72 US$280,300
2021-04-13 2021-04-12 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
48 -0.0%
22.68
US$1,089 		48 -0.0% 22.68 US$1,089
2021-04-13 2021-04-12 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
811 -0.0%
21.52
US$17,453 		811 -0.0% 21.52 US$17,453
2021-04-13 2021-04-12 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
1,637 -0.1%
20.72
US$33,919 		1,637 -0.1% 20.72 US$33,919
2021-04-13 2021-04-09 PlS Planned sale
3.1
GADICKE ANSBERT
Large shareholder
10,300 -0.1%
23.67
US$243,801 		10,300 -0.1% 23.67 US$243,801
2021-04-13 2021-04-09 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
10,300 -0.3%
23.67
US$243,801 		10,300 -0.3% 23.67 US$243,801
2021-04-05 2021-04-01 PlS Planned sale
Wesche Holger

Chief Scientific Officer

Officer
500 -0.9%
21.14
US$10,570 		500 -0.9% 21.14 US$10,570
2021-04-05 2021-04-01 PlS Planned sale
Wesche Holger

Chief Scientific Officer

Officer
9,500 -15.1%
20.41
US$193,921 		9,500 -15.1% 20.41 US$193,921
2021-02-12 2021-02-10 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
183,051 -5.4%
20.00
US$3,661,020 		183,051 -5.4% 20.00 US$3,661,020
2021-02-09 2021-02-09 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
9,400 -0.3%
20.25
US$190,350 		9,400 -0.3% 20.25 US$190,350
2021-02-09 2021-02-08 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
72,128 -2.1%
20.04
US$1,445,445 		72,128 -2.1% 20.04 US$1,445,445
2021-02-09 2021-02-05 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
10,172 -0.3%
20.01
US$203,542 		10,172 -0.3% 20.01 US$203,542
2021-02-04 2021-02-04 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
29,730 -0.8%
20.37
US$605,600 		29,730 -0.8% 20.37 US$605,600
2021-02-04 2021-02-03 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
41,922 -1.2%
20.21
US$847,244 		41,922 -1.2% 20.21 US$847,244
2021-02-04 2021-02-02 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
48,421 -1.3%
20.13
US$974,715 		48,421 -1.3% 20.13 US$974,715
2021-01-27 2021-01-27 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
706,825 -16.3%
20.00
US$14,136,500 		706,825 -16.3% 20.00 US$14,136,500
2021-01-27 2021-01-26 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
1,363 -0.0%
21.08
US$28,732 		1,363 -0.0% 21.08 US$28,732
2021-01-27 2021-01-25 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
13,006 -0.3%
21.23
US$276,117 		13,006 -0.3% 21.23 US$276,117
2021-01-22 2021-01-22 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
24,695 -0.6%
21.72
US$536,375 		24,695 -0.6% 21.72 US$536,375
2021-01-22 2021-01-21 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
200 -0.0%
23.77
US$4,754 		200 -0.0% 23.77 US$4,754
2021-01-22 2021-01-21 PlS Planned sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
4,887 -0.1%
22.61
US$110,495 		4,887 -0.1% 22.61 US$110,495
Explore more

More insider trading research around Harpoon Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America